Journal of Public Health Policy

, Volume 35, Issue 2, pp 219–238 | Cite as

The skin whitening industry in the Philippines

  • Roger Lee Mendoza
Original Article


Skin whitening is a big and booming industry in many developing countries. Its popularity owes mainly to post-colonial, internalized racism. This study examines whether government intervention is necessary and more efficient than market-driven approaches in addressing the health risks and harms associated with skin whitening. We gathered empirical data on the quality and quantity of health-related information about skin whiteners with a multi-stage probability sample of consumers in two cities in the Philippines (n=110; α=0.05). Regardless of their socio-demographic characteristics, we find that cognitive biases and information asymmetries build and sustain consumers’ trust in manufacturers and distributors of skin whiteners while, paradoxically, breeding uncertainties over the integrity of these products. The results are product adulteration and misbranding, leading to pricing advantages for toxic whiteners over safer products. This has impeded regulatory efficacy. We recommend anchoring government intervention in transaction cost-reduction, containing the externalities of skin bleaching, and institutionalizing third party partnerships. Failure to do so would leave consumers extremely vulnerable to the forces of supply and demand that favor toxic whiteners, particularly in a market where voluntary collective action is difficult to organize.


skin whitening toxicity asymmetric information cognitive biases externalities rent-seeking transaction costs 


  1. Mire, A. (2001) Skin-bleaching: Poison, beauty, power, and the politics of the colour line. Resources for Feminist Research 28 (3): 13–37.Google Scholar
  2. Blay, Y.A. (2011) Skin bleaching and global white supremacy: By way of introduction. The Journal of Pan African Studies 4 (4): 4–46.Google Scholar
  3. Pitche, P., Kombate, K. and Tchangai-Walla, K. (2005) Cosmetic use of skin bleaching products and associated complications. International Journal of Dermatology 44 (1): 39–40.CrossRefGoogle Scholar
  4. DiMasi, J.A., Hansen, R.W. and Grabowski, H.G. (2003) The price of innovation: New estimates of drug development costs. Journal of Health Economics 22 (1): 151–185.CrossRefGoogle Scholar
  5. European Commission-Directorate General Enterprise and Industry. (2007) Impact of European Regulation on the EU Cosmetics Industry. Norfolk, UK: Risk & Policy Analysts.Google Scholar
  6. Friedman, D.D. (1991) Should medicine be a Commodity? An economist’s perspective. In: T.J. Bole III. and W.B. Bondeson (eds.) Rights to Health Care. The Netherlands: Kluwer Academic Publishers, pp. 259–306.CrossRefGoogle Scholar
  7. Synovate Philippines. (2004) Skin Whitening in Southeast Asia. Pasig City, Philippines: Synovate.Google Scholar
  8. Bureau of Food and Drugs. (2004) Bureau Circular No. 4-B, 3 April.Google Scholar
  9. Republic Act No. 9711. (2009) 18 August.Google Scholar
  10. Food and Drug Administration. (2011) Advisory No. 2011-012, 4 August.Google Scholar
  11. Cebu Daily News. (2011) DOH to confiscate mercury-loaded whitening creams. Philippine Inquirer, 9 August.Google Scholar
  12. EcoWaste Coalition. (2012) Watchdog Bares 5 More Skin Whitening Cosmetics with Toxic Mercury,, accessed 9 December.
  13. EcoWaste Coalition. (2011) Groups Laud FDA Ban on 50 Mercury-Tainted Skin Whitening Products,, accessed 6 August.
  14. Department of Health/Food and Drug Administration. (2012) Advisory No. 2012-018, 28 November.Google Scholar
  15. House of Representatives Bill No. 3508. (2010) 15th Congress, 29 July.Google Scholar
  16. Andrade, J.I. (2013) Toxic skin creams still sold in Divisoria, Quiapo. Philippine Daily Inquirer, 22 April.Google Scholar
  17. Zambrano, C. (2010) FDA confiscates illegal whitening products, sex pills. ABS-CBN News, 10 December.Google Scholar
  18. Naval, G. (2013) Banned cosmetic products still on sale. Malaya. February 4, p. 2.Google Scholar
  19. Dacanay, B.M. (2011) Filipinos warned against use of killer whiteners. Gulf News, 31 May, p. 14.Google Scholar
  20. EcoWaste Coalition. (2011a) EcoWaste Coalition Goes to Senate to Push for Safe Cosmetics Act,, accessed 3 August.
  21. Akerlof, G. (1970) The market for lemons: Quality uncertainty and the market mechanism. Quarterly Journal of Economics 84 (3): 488–500.CrossRefGoogle Scholar
  22. Krueger, A.O. (1974) The political economy of the rent seeking society. American Economic Review 64 (3): 291–303.Google Scholar
  23. Barzel, Y. (1982) Measurement cost and the organization of markets. Journal of Law and Economics 25 (1): 27–48.CrossRefGoogle Scholar
  24. Cooper, R. and Ross, T. (1984) Prices, product qualities, and asymmetric information: The competitive case. Review of Economic Studies 51 (2): 197–207.CrossRefGoogle Scholar
  25. Cooter, R. and Ulen, T. (1988) Law and economics. New York: Harper Collins Publishers.Google Scholar
  26. Dahlman, C.J. (1979) The problem of externality. Journal of Law and Economics 22 (1): 141–162.CrossRefGoogle Scholar
  27. Krimsky, S. (2003) Science in the Private Interest: Has the Lure of Profits Corrupted Biomedical Research? Lanham, MD: Rowman & Littlefield Publishers.Google Scholar
  28. City of New York, Department of Consumer Affairs. (1992) A Study in Hype and Risk: The Marketing of Skin Bleaches. New York: Department of Consumer Affairs,
  29. Saint Louis, C. (2010) Creams Offering Lighter Skin May Bring Risks. New York Times. January 16, p. A-1.Google Scholar

Copyright information

© Palgrave Macmillan, a division of Macmillan Publishers Ltd 2013

Authors and Affiliations

  • Roger Lee Mendoza
    • 1
  1. 1.School of Business, Wilmington UniversityNew CastleUSA

Personalised recommendations